Ionis Pharmaceuticals, Inc.

IONS · NASDAQ
Analyze with AI
10/28/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$338,341$297,304$264,192$242,077
Short-Term Investments$1,901,830$1,992,676$1,880,960$2,055,579
Receivables$25,000$52,580$39,707$92,188
Inventory$10,470$8,481$11,502$12,512
Other Curr. Assets$243,523$226,109$222,571$217,934
Total Curr. Assets$2,518,993$2,577,150$2,418,932$2,620,290
Property Plant & Equip (Net)$348,110$275,884$262,194$256,107
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$52,210$22,816$41,023$41,023
Tax Assets$0$0$0$0
Other NC Assets$113,778$109,283$90,799$86,255
Total NC Assets$514,098$407,983$394,016$383,385
Other Assets$0$0$0$0
Total Assets$3,033,091$2,985,133$2,812,948$3,003,675
Liabilities
Payables$14,326$22,800$17,456$42,964
Short-Term Debt$630,911$630,118$12,002$9,279
Tax Payable$0$81$126$34
Deferred Revenue$76,986$75,910$81,097$78,989
Other Curr. Liab.$81,822$69,370$36,877$69,614
Total Curr. Liab.$903,456$897,236$250,293$309,318
LT Debt$595,908$625,494$1,786,859$1,245,485
Deferred Rev, NC$107,906$125,095$140,678$156,504
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$545,182$541,205$140,678$542,212
Total NC Liab.$1,511,668$1,456,173$2,086,929$2,106,006
Other Liabilities$0$0$0$0
Cap. Leases$291,457$164,000$159,392$161,805
Total Liabilities$2,415,124$2,353,409$2,337,222$2,415,324
Equity
Pref Stock$0$0$0$0
Common Stock$161$159$159$158
Retained Earnings-$2,401,801-$2,273,195-$2,396,746-$2,249,808
AOCI-$25,978-$27,987-$28,949-$30,811
Other Equity$0$0$0$0
Total Equity$617,967$631,724$475,726$588,351
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$3,033,091$2,985,133$2,812,948$3,003,675
Net Debt$888,478$958,308$1,534,669$1,012,687
Ionis Pharmaceuticals, Inc. (IONS) Financial Statements & Key Stats | AlphaPilot